PMID- 20387912
OWN - NLM
STAT- MEDLINE
DCOM- 20100819
LR  - 20211020
IS  - 1179-2027 (Electronic)
IS  - 1170-7690 (Linking)
VI  - 28
IP  - 6
DP  - 2010
TI  - Does the inclusion of a cost attribute result in different preferences for the 
      surgical treatment of primary basal cell carcinoma?: a comparison of two 
      discrete-choice experiments.
PG  - 507-20
LID - 10.2165/11532240-000000000-00000 [doi]
AB  - BACKGROUND: Nowadays, an increasing number of discrete-choice experiments (DCEs) 
      incorporate cost as an attribute. However, the inclusion of a cost attribute, 
      particularly within collectively funded healthcare systems, can be challenging 
      because health services or goods are generally not traded in a market situation 
      and individuals are not used to paying for a service or a good at the point of 
      consumption. OBJECTIVE: To examine whether the inclusion of a cost attribute in a 
      DCE results in different preferences regarding a surgical treatment for primary 
      basal cell carcinoma (BCC) compared with a DCE without a cost attribute. METHODS: 
      A randomized study was performed in which the impact of a cost attribute on the 
      general public's preferences for a surgical treatment (Mohs micrographic surgery 
      [MMS] or standard excision [SE]) to remove BCC was examined. This was done by 
      comparing the outcomes of two DCEs, one with a cost attribute (DCE_cost) and one 
      without (DCE_nocost). Six attributes (recurrence, re-excision, travel time, 
      surgical time, waiting time for surgical results, costs) and their levels were 
      selected, based on results of a clinical trial, a cost-effectiveness study, a 
      review and a focus group of patients who had recently received treatment for BCC. 
      Outcomes of both DCEs were compared in terms of theoretical validity, relative 
      importance of the attributes and the rank order of preferences. RESULTS: A total 
      of 615 respondents (n = 303 for DCE_nocost; n = 312 for DCE_cost) were 
      interviewed by telephone. This gave an overall response rate of 38%. Respondents 
      in DCE_nocost preferred a surgical treatment with a lower probability of 
      recurrence, lower surgery time, lower waiting time and no risk for a re-excision. 
      Respondents in DCE_cost showed the same preferences, but also preferred a 
      treatment with less travel time and lower costs. Overall, respondents in both 
      DCEs showed the same preference for a surgical treatment: MMS was preferred over 
      SE. CONCLUSION: Results suggest that, in this population, the inclusion of a cost 
      attribute in a DCE leads to the same preference regarding a surgical treatment to 
      remove BCC as a DCE without a cost attribute. However, further research in 
      different settings is needed to confirm these findings.
FAU - Essers, Brigitte A B
AU  - Essers BA
AD  - Department of Clinical Epidemiology and Medical Technology Assessment, University 
      Hospital Maastricht, 6202 AZ Maastricht, the Netherlands. brigitte.essers@mumc.nl
FAU - van Helvoort-Postulart, Debby
AU  - van Helvoort-Postulart D
FAU - Prins, Martin H
AU  - Prins MH
FAU - Neumann, Martino
AU  - Neumann M
FAU - Dirksen, Carmen D
AU  - Dirksen CD
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - New Zealand
TA  - Pharmacoeconomics
JT  - PharmacoEconomics
JID - 9212404
MH  - Adult
MH  - Carcinoma, Basal Cell/*economics/*surgery
MH  - *Choice Behavior
MH  - Cost-Benefit Analysis/*methods
MH  - Female
MH  - *Health Care Costs
MH  - Humans
MH  - Male
MH  - Patient Preference/*economics/statistics & numerical data
MH  - Skin Neoplasms/*surgery
EDAT- 2010/04/15 06:00
MHDA- 2010/08/20 06:00
CRDT- 2010/04/15 06:00
PHST- 2010/04/15 06:00 [entrez]
PHST- 2010/04/15 06:00 [pubmed]
PHST- 2010/08/20 06:00 [medline]
AID - 10.2165/11532240-000000000-00000 [doi]
PST - ppublish
SO  - Pharmacoeconomics. 2010;28(6):507-20. doi: 10.2165/11532240-000000000-00000.